Screening system for chemicals attacking pre-mRNA splicing machinery in cells
Screening system for chemicals attacking pre-mRNA splicing machinery in cells
批准号:
13670334
负责人:
NISHIO Hisahide
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It has been expected that some environmental chemicals attack the cellular splicing machinery to block the gene functions. Such chemicals, however, have never been reported so far. During our investigation of some inherited disorders with abnormal splicing pattern of the genes, we established splicing assay system with artificial pre-mRNA. In 2001, we constructed a mini-gene, of which transcripts were used as pre-mRNA. This mini-gene was a chimeric plasmid which consisted of T7 promoter, the third exon-the third intron-the 5' part of the fourth exon of the Drosophila melanogaster double sex gene (dsx) and splicing enhancer sequences (SES) selected from exons of the human dystrophin gene.In 2002, we performed splicing assays using the mini-genes in the HeLa nuclear extract. High splicing efficiency was observed in the assays using the mini-genes with SESs from exons 19 and 26, When anti-SMN antibody was added in the HeLa nuclear extract, splicing reaction using the mini-gene with SES fr … More om exon 19 was blocked but splicing reaction using the mini-gene with SES from exon 26 was not blocked. The anti-SMN antibody is against the SMN protein, which is a product of the responsible gene for spinal muscular atrophy. when cadmium chloride (CdC12) solution was added in the HeLa nuclear extract, splicing reaction using the mini-gene with SES from exon 19 was blocked. The degree of splicing blockade was dependent on the CdC12 concentration.These findings suggest that splicing efficiency is, at least partly, dependent on the SESs ; some chemical may affect splicing of some exons, but the same chemical may not affect splicing of the other exons. We can also expect that some chemical may affect splicing of some exons in the HeLa nuclear extract, but the same chemical may not affect splicing of the same exons in the non-HeLa nuclear extract. However, our preliminary study showed a new kind of cadmium toxicity affecting splicing machinery. In addition, the present study with anti-SMN antibody gives some clues to understanding of the pathogenesis of spinal muscular atrophy. Less
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ito.T, Takeshima Y, Nakamura H, Matsuo M.: "One of three examined purine-rich sequences selected from dystrophin exons exhibits splicing enhancer activity"Acta Myologic. 20巻. 151-153 (2001)
Ito.T、Takeshima Y、Nakamura H、Matsuo M.:“从抗肌营养不良蛋白外显子中选择的三个富含嘌呤的序列之一表现出剪接增强子活性”Acta Myologic。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
竹島泰弘, 松尾雅文: "アンチセンス・オリオヌクレオチドを用いたエクソンスキッピング誘導による遺伝子治療"別冊実験医学 ザ・プロトコールシリーズ 遺伝子の機能障害実験 簡単で確実な遺伝子機能解析からの遺伝子治療への応用まで. 175-182 (2001)
Yasuhiro Takeshima,Masafumi Matsuo:“使用反义核苷酸诱导外显子跳跃的基因治疗”实验医学特刊协议系列基因功能障碍实验从简单可靠的基因功能分析到基因治疗的应用175-182(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ito.T, Takeshima Y, Sakamoto H, Nakamura H, Matsuo M.: "Purine-rich exon sequences are not necessarily splicing enhancer sepquence in the dystrophin gene"Kobe. J. Med. Sci.. 47巻. 193-2002 (2001)
Ito.T、Takeshima Y、Sakamoto H、Nakamura H、Matsuo M.:“富含嘌呤的外显子序列不一定是抗肌营养不良蛋白基因中的剪接增强子序列”Kobe J. Sci. 47. 193-2002。 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Harada Y: "Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy : three SMN2 copies fail to rescue some patients from the disease severity"J.Neurol.. 249. 1211-1219 (2002)
Harada Y:“SMN2 拷贝数与脊髓性肌萎缩症临床表型之间的相关性:三个 SMN2 拷贝未能挽救一些患者的疾病严重程度”J.Neurol.. 249. 1211-1219 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Establishment of treatment strategy for spinal muscular atrophybased on the SMN2gene transcription control
-
批准号:22591127
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:NISHIO Hisahide
-
依托单位:
Development of Therapy for Spinal Muscular Atrophy Based on the Spliring Modulation Technology
-
批准号:18591151
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2006
-
负责人:NISHIO Hisahide
-
依托单位:
Molecular epidemiology of neonatal Gilbert's syndrome in Malaysia
-
批准号:15406036
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.36万
-
财政年份:2003
-
负责人:NISHIO Hisahide
-
依托单位:
Molecular biological studies on environmental chemical pollutants interfering with endocrine systems
-
批准号:10670350
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1998
-
负责人:NISHIO Hisahide
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CircSLTM及其编码多肽SLTM-99aa通过SAFB介导的mRNA剪接重塑在胃癌发生发展中的分子机制及其临床价值研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡柯峰
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
-
批准号:81071809
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:张旭东
-
依托单位:
c-Abl调控U2AF65介导的mRNA剪接及核质转运机制研究
-
批准号:31070674
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:李晓明
-
依托单位:
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
-
批准号:30971223
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:朱健华
-
依托单位:
CIP4剪接突变体在肾小管上皮细胞转分化的作用及机制研究
-
批准号:30871172
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:徐钢
-
依托单位:
基于数据库的蛋白自剪切综合分析及实验
-
批准号:30470356
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2004
-
负责人:谢君
-
依托单位: